Clozapine use and outcomes among patients with treatment resistant schizophrenia

REFERENCES

• Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. European Archives of Psychiatry and Clinical Neuroscience 2000; 250: 274–285.
   PubMed Web of Science ®Google Scholar
• Kulhara P, Chakrabarti S. Culture and schizophrenia and other psychotic disorders. Psychiatric Clinics of North America 2001; 24: 449–464.
   PubMed Web of Science ®Google Scholar
• Conley RR, Kelly DL. Management of treatment-resistant schizophrenia. Biological Psychiatry 2001; 50: 898–911.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. APA Practice Guidelines for the Treatment of Psychiatric Disorders: Compendium 2006. Washington DC: APA.
   Google Scholar
• Lindenmayer JP. Treatment refractory schizophrenia. Psychiatric Quarterly 2000; 71: 373–384.
   PubMed Web of Science ®Google Scholar
• Kerwin R. When should clozapine be initiated in schizophrenia? Some arguments for and against earlier use of Clozapine. CNS Drugs 2007; 21: 267–278.
   Google Scholar
• Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. American Journal of Psychiatry 2001; 158: 518–526.
   PubMed Web of Science ®Google Scholar
• Gaines P, Bower A, Buckingham W, Eagar K, Burgess P, Green J. New Zealand Mental Health Classification and Outcomes Study: Final Report. Auckland: Health Research Council of New Zealand, 2003.
   Google Scholar
• Eagar K, Gaines P, Burgess P . Developing a New Zealand casemix classification for mental health services. World Psychiatry 2004; 3:172–177.
   PubMedGoogle Scholar
• MaGPIe Research Group. Mental disorders among Maori attending their general practitioner. Australian and New Zealand Journal of Psychiatry 2005; 39: 401–406.
   Google Scholar
• Baxter J, Kokaua J, Wells JE, McGee MA, Oakley Browne MA, for the New Zealand Mental Health Survey Research Team. Ethnic comparisons of the 12 month prevalence of mental disorders and treatment contact in Te Rau Hinengaro: the New Zealand Mental Health Survey. Australian and New Zealand Journal of Psychiatry 2006; 40: 905–913.
   PubMed Web of Science ®Google Scholar
• Tapsell R, Mellsop G. The contributions of culture and ethnicity to New Zealand mental health research findings. International Journal of Social Psychiatry 2007; 53: 317–24.
   PubMed Web of Science ®Google Scholar
• Mellsop G, Dutu G, El-Badri S. CAOS contribution to understanding cultural/ethnic differences in the prevalence of bipolar affective disorder in New Zealand. Australian and New Zealand Journal of Psychiatry 2007; 41: 392–396.
   PubMed Web of Science ®Google Scholar
• Wing J K, Beevor AS, Curtis RH, Park S, Hadden S, Burns A. Health of the Nation Outcome Scales (HoNOS). British Journal of Psychiatry 1998; 172: 11–18.
   Google Scholar
• Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM. Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia. Psychiatric Quarterly 2006; 77: 81–95.
   PubMed Web of Science ®Google Scholar
• Wheeler, A. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Annals of Pharmacotherapy 2008; 42: 852–860.
   PubMed Web of Science ®Google Scholar
• Susser E, Wanderling J. Epidemiology of nonaffective acute remitting psychosis vs schizophrenia. Sex and sociocultural setting. Archives of General Psychiatry 1994; 51: 294–301.
   PubMed Web of Science ®Google Scholar
• Navarro F, van Os J, Jones P, Murray R. Explaining sex differences in course and outcome in the functional psychoses. Schizophrenia Research 1996; 21: 161–170.
   PubMed Web of Science ®Google Scholar
• Szymanski S, Lieberman J, Pollack S . Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics. Biological Psychiatry 1996; 39: 249–254.
   PubMed Web of Science ®Google Scholar
• Werry JS. Child and adolescent (early onset) schizophrenia: a review in light of DSM-III-R. Journal of Autism and Developmental Disorders 1992; 22: 601–624.
   PubMed Web of Science ®Google Scholar
• Tiihonen J, Lönnqvist J, Wahlbeck K . 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009; 374: 620–627.
   PubMed Web of Science ®Google Scholar